DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
1496
DROSPIRENONE; ETHINYL ESTRADIOL
4
Combination
Approved
OTHER; PREGNANCY AND GYNECOLOGY
ORAL; ORAL-28
Unknown
Unknown
DROSPIRENONE; ETHINYL ESTRADIOL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE
4
Combination
Approved
OTHER; UROLOGY AND KIDNEY
ORAL
Unknown
Unknown
DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EFAVIRENZ;EMTRICITABINE;TENOFOVIR DISOPROXIL FUMARATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
EFAVIRENZ;EMTRICITABINE;TENOFOVIR DISOPROXIL FUMARATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EFAVIRENZ;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
EFAVIRENZ;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EMTRICITABINE;TENOFOVIR DISOPROXIL FUMARATE;NEVIRAPINE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
EMTRICITABINE;TENOFOVIR DISOPROXIL FUMARATE;NEVIRAPINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ENALAPRIL MALEATE; FELODIPINE
4
Combination
Approved
DIABETES DRUGS & ENDOCRINOLOGY; OTHER
ORAL
Unknown
Unknown
ENALAPRIL MALEATE; FELODIPINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EPINEPHRINE BITARTRATE; ETIDOCAINE HYDROCHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
EPINEPHRINE BITARTRATE; ETIDOCAINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EPINEPHRINE BITARTRATE; PRILOCAINE HYDROCHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
EPINEPHRINE BITARTRATE; PRILOCAINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EPINEPHRINE; ETIDOCAINE HYDROCHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
EPINEPHRINE; ETIDOCAINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE
4
Combination
Approved
OTHER; PHARMACOLOGY
INJECTION; IONTOPHORESIS; TOPICAL
Unknown
Unknown
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EPINEPHRINE; PROCAINE HYDROCHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
EPINEPHRINE; PROCAINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ERYTHROMYCIN ESTOLATE; SULFISOXAZOLE ACETYL
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ERYTHROMYCIN ESTOLATE; SULFISOXAZOLE ACETYL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ESOMEPRAZOLE MAGNESIUM; NAPROXEN
4
Combination
Approved
GASTROINTESTINAL; OTHER; RHEUMATOLOGY
ORAL
Unknown
Unknown
ESOMEPRAZOLE MAGNESIUM; NAPROXEN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ESTRADIOL CYPIONATE; MEDROXYPROGESTERONE ACETATE
4
Combination
Approved
OTHER
INTRAMUSCULAR
Unknown
Unknown
ESTRADIOL CYPIONATE; MEDROXYPROGESTERONE ACETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ESTRADIOL CYPIONATE; TESTOSTERONE CYPIONATE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
ESTRADIOL CYPIONATE; TESTOSTERONE CYPIONATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ESTRADIOL HEMIHYDRATE
4
Small molecule
Approved
OTHER
TOPICAL
Unknown
Unknown
ESTRADIOL HEMIHYDRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ESTRADIOL; LEVONORGESTREL
4
Combination
Approved
OTHER
TRANSDERMAL
Unknown
Unknown
ESTRADIOL; LEVONORGESTREL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ESTRADIOL; NORETHINDRONE ACETATE
4
Combination
Approved
MUSCULOSKELETAL; OTHER
ORAL; TRANSDERMAL
Unknown
Unknown
ESTRADIOL; NORETHINDRONE ACETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ESTRADIOL; NORGESTIMATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ESTRADIOL; NORGESTIMATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ESTRADIOL VALERATE; TESTOSTERONE ENANTHATE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
ESTRADIOL VALERATE; TESTOSTERONE ENANTHATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE
4
Combination
Approved
DIABETES DRUGS & ENDOCRINOLOGY; MUSCULOSKELETAL; OTHER; PREGNANCY AND GYNECOLOGY
ORAL-28
Unknown
Unknown
ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ESTROGENS, CONJUGATED; MEPROBAMATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ESTROGENS, CONJUGATED; MEPROBAMATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ESTROGENS, CONJUGATED SYNTHETIC B
4
Small molecule
Approved
OTHER
ORAL
Unknown
Unknown
ESTROGENS, CONJUGATED SYNTHETIC B
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ETHINYL ESTRADIOL; ETHYNODIOL DIACETATE
4
Combination
Approved
OTHER
ORAL-21; ORAL-28
Unknown
Unknown
ETHINYL ESTRADIOL; ETHYNODIOL DIACETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE
4
Combination
Approved
OTHER
ORAL-28
Unknown
Unknown
ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE ACETATE
4
Combination
Approved
OTHER
ORAL-28
Unknown
Unknown
ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE ACETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ETHINYL ESTRADIOL; LEVONORGESTREL
4
Combination
Approved
OTHER; PREGNANCY AND GYNECOLOGY
ORAL; ORAL-21; ORAL-28
Unknown
Unknown
ETHINYL ESTRADIOL; LEVONORGESTREL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
32
33
34
35
36
37
38
…
42
43
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA